Unraveling the pathogenesis of type 1 diabetes with proteomics: present and future directions.
about
Mitochondria in the pathogenesis of diabetes: a proteomic viewZinc transporter gene expression is regulated by pro-inflammatory cytokines: a potential role for zinc transporters in beta-cell apoptosis?Mitochondria in Alzheimer's Disease and Diabetes-Associated Neurodegeneration: License to Heal!Screening newborns for candidate biomarkers of type 1 diabetes.Involvement of microRNAs in the cytotoxic effects exerted by proinflammatory cytokines on pancreatic beta-cells.Advances and challenges in biomarker development for type 1 diabetes prediction and prevention using omic technologiesEpigallocatechin gallate delays the onset of type 1 diabetes in spontaneous non-obese diabetic mice.Unraveling pancreatic islet biology by quantitative proteomics.Development of a type II diabetic mellitus animal model using Micropig®.Type 1 diabetes: entering the proteomic era.Dietary flavonol epicatechin prevents the onset of type 1 diabetes in nonobese diabetic mice.Regulation of insulin synthesis and secretion and pancreatic Beta-cell dysfunction in diabetes.The beta-cell in type 1 diabetes: What have we learned from proteomic studies?SEAP activity serves for demonstrating ER stress induction by glucolipotoxicity as well as testing ER stress inhibitory potential of therapeutic agents.Production of Cloned Wuzhishan Miniature Pigs and Application for Alloxan Toxicity Test.Proteomics analysis of cytokine-induced dysfunction and death in insulin-producing INS-1E cells: new insights into the pathways involved.Etiopathogenesis of type 1 diabetes mellitus: prognostic factors for the evolution of residual beta cell function.ERp46 is reduced by high glucose and regulates insulin content in pancreatic beta-cells.The progress and potential of proteomic biomarkers for type 1 diabetes in children.Proteomic analysis to identify candidate biomarkers associated with type 1 diabetes.
P2860
Q28394886-83355A84-2C4A-40FC-881B-A8CAA95F9B09Q28566179-92ECBA18-4E4E-4DD5-8DF4-1BA3033161CCQ33364882-E239D5BB-F789-4B12-8E2E-35C960D0B791Q33702590-8AF1B5F6-B88C-42C4-8730-7E2B88EDD34BQ33750755-AC8CBC90-3E8A-4F8A-8180-0639E685B674Q34157932-B872F4AF-03D0-41C6-A29B-A38ACCEF4A56Q35105316-45833427-A1A9-48E1-B76E-E3EDEA1B91B2Q35178704-CD2D7AE8-FBDC-407A-B199-5E7E7DD1B9BDQ36313243-6A61ED37-385A-43E5-AA78-5A7068CB7D08Q36445582-FF842D0D-0EBE-424C-B7AD-8F3A6AFF40FDQ36863398-353E2CDE-5C94-4F28-86DF-E9BEF6B2C276Q37603286-E0AAC1BD-5436-4BED-8BD2-742D4398A774Q38340362-42ABFB7D-D924-4EE9-8F98-1ABAFA3421B1Q38899151-75A2E389-B78F-4687-89DC-BF7DFEF6928FQ38986573-03B80B8B-2F0A-48D1-8D0F-CAC1A3130AA7Q40070947-281A2E75-634E-486E-8207-6DA895A77907Q42041838-23DA9492-7C4F-4089-A66C-3E9D2744F710Q45923702-E3DA10CB-DF8D-49A7-A328-9387400F9271Q48720838-E3AF4438-35E5-4D89-9CF4-709E8C0DD2EDQ55283288-EE4AE83D-9F57-4C88-890C-826FB8BF5997
P2860
Unraveling the pathogenesis of type 1 diabetes with proteomics: present and future directions.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Unraveling the pathogenesis of ...... present and future directions.
@ast
Unraveling the pathogenesis of ...... present and future directions.
@en
type
label
Unraveling the pathogenesis of ...... present and future directions.
@ast
Unraveling the pathogenesis of ...... present and future directions.
@en
prefLabel
Unraveling the pathogenesis of ...... present and future directions.
@ast
Unraveling the pathogenesis of ...... present and future directions.
@en
P2093
P2860
P1476
Unraveling the pathogenesis of ...... present and future directions.
@en
P2093
Allan E Karlsen
Ole N Jensen
Peter E Heding
Thomas Sparre
P2860
P304
P356
10.1074/MCP.R500002-MCP200
P577
2005-02-07T00:00:00Z